russ2000_2_0209|EIDX|Short Name|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
russ2000_2_0209|EIDX|Long Name|Eidos Therapeutics Inc Total Current Assets (Quarterly) (USD)|Eidos Therapeutics Inc Cash and Short Term Investments (Quarterly) (USD)|Eidos Therapeutics Inc Inventories (Quarterly) (USD)|Eidos Therapeutics Inc Net PP&E (Quarterly) (USD)|Eidos Therapeutics Inc Goodwill and Intangibles (Quarterly) (USD)|Eidos Therapeutics Inc Total Liabilities (Quarterly) (USD)|Eidos Therapeutics Inc Total Current Liabilities (Quarterly) (USD)|Eidos Therapeutics Inc Total Long Term Liabilities (Quarterly) (USD)|Eidos Therapeutics Inc Total Deposits (Quarterly) (USD)|Eidos Therapeutics Inc Book Value (Quarterly) (USD)|Eidos Therapeutics Inc Retained Earnings (Quarterly) (USD)|Eidos Therapeutics Inc Treasury Stock (Quarterly) (USD)|Eidos Therapeutics Inc EV to Revenues|Eidos Therapeutics Inc EV to Earnings|Eidos Therapeutics Inc EV to Free Cash Flow|Eidos Therapeutics Inc EV to Assets (Quarterly)|Eidos Therapeutics Inc PS Ratio|Eidos Therapeutics Inc PE Ratio|Eidos Therapeutics Inc Price to Book Value|Eidos Therapeutics Inc PEG Ratio|Eidos Therapeutics Inc Debt to Equity Ratio|Eidos Therapeutics Inc Dividend Yield|Eidos Therapeutics Inc Shareholder Yield (TTM)|Eidos Therapeutics Inc Percent of Shares Outstanding Short|Eidos Therapeutics Inc Total Receivables (Quarterly) (USD)|Eidos Therapeutics Inc Total Payables (Quarterly) (USD)|Eidos Therapeutics Inc Total Capital Stock (Quarterly) (USD)|Eidos Therapeutics Inc Return on Invested Capital|Eidos Therapeutics Inc Quality Ratio Score|Eidos Therapeutics Inc Momentum Score|Eidos Therapeutics Inc Beta (1Y)|Eidos Therapeutics Inc Sustainable Growth Rate (TTM)|Eidos Therapeutics Inc Institutional Investor Ownership Percentage|Eidos Therapeutics Inc Average Diluted Shares Outstanding (Quarterly)|Eidos Therapeutics Inc Total Employees (Annual)|Eidos Therapeutics Inc EPS Diluted (Quarterly) (USD)|Eidos Therapeutics Inc Dividend Per Share (Quarterly) (USD)|Eidos Therapeutics Inc Revenue (Quarterly) (USD)|Eidos Therapeutics Inc Gross Profit (Quarterly) (USD)|Eidos Therapeutics Inc SG&A Expense (Quarterly) (USD)|Eidos Therapeutics Inc Pre-Tax Income (Quarterly) (USD)|Eidos Therapeutics Inc Net Income (Quarterly) (USD)|Eidos Therapeutics Inc Net Interest Income (Quarterly) (USD)|Eidos Therapeutics Inc Price (USD)|Eidos Therapeutics Inc Total Return Price (USD)|Eidos Therapeutics Inc Enterprise Value (USD)|Eidos Therapeutics Inc 30-Day Average Daily Volume|Eidos Therapeutics Inc 1 Year Price Returns (Daily)||
russ2000_2_0209|EIDX|Unit|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
russ2000_2_0209|EIDX|201703||||||||||||||||||||||||||||||||||19.5748||-0.1196||||0.378|-2.342|-2.342||||||||
russ2000_2_0209|EIDX|201706||||||||||||||||||||||||||||||||||19.5748||-0.0876||||0.454|-1.715|-1.715||||||||
russ2000_2_0209|EIDX|201709||||||||||||||||||||||||||||||||||19.5748||-0.1417||||0.49|-2.773|-2.773||||||||
russ2000_2_0209|EIDX|201712|6.048|5.497||0.114||19.539|2.238|17.301||-13.196|-14.532||||||||||||||0.067|0.938|0.004|||||||19.5748||-0.2611||||1.408|-5.111|-5.111||||||||
russ2000_2_0209|EIDX|201803|25.969|25.269||0.218||54.649|4.738|49.911||-25.826|-30.111||||||||||||||0.076|1.994|0.004|||||||35.8145|14|-0.2223||||2.345|-8.876|-8.876||||||||
russ2000_2_0209|EIDX|201806|178.955|176.689||0.219||5.699|5.296|0.403||173.644|-40.732||||-50.3976|||||||0||0.6679|0.021|2.665|0.037|||||||8.1097||-1.4||||1.894|-11.381|-11.381||20.34|20.34|703.1979|||20.32|20.32
russ2000_2_0209|EIDX|201809|169.845|166.568||0.218||6.407|6.05|0.357||163.819|-50.908||||-8.9009||||2.1123|||0||2.8303|0.029|2.623|0.037|||||||35.9658||-0.3|||0|2.619|-10.614|-10.614||9.98|9.98|190.096|241927.9667||9.92|9.92
russ2000_2_0209|EIDX|201812|158.97|157.147||0.209||5.105|4.789|0.316||155.007|-65.27||||-10.4235||||3.2632|||0||4.4591|0.034|2.212|0.037|||||||36.7605|24|-0.27|||0|2.382|-9.854|-9.854||13.76|13.76|348.6775|169427.4333||14.03|14.03
russ2000_2_0209|EIDX|201903|149.296|147.064||1.249||8.896|7.841|1.055||144.301|-77.003||||-21.0722||||5.5613|||0||6.9444|0.072|3.619|0.037|||||||36.1755||-0.32||||4.035|-11.733|-11.733|0|23.45|23.45|704.8867|185595.6333||23.54|23.54
russ2000_2_0209|EIDX|201906|135.525|131.4||1.192||7.435|6.489|0.946||131.846|-91.056||||-26.5627||||7.932|||0||9.4762|0.197|2.186|0.037||||-0.8396|||36.3097|36|-0.39||||2.297|-14.053|-14.053|0|31.08|31.08|997.5347|192508.7|56.1025|32.42|32.42
russ2000_2_0209|EIDX|201909|171.307|165.822||5.32||14.94|10.075|4.865||163.954|-84.125||||-47.5225|6.6125|||8.2264||0|0||7.6199|0.083|3.939|0.038|||10|-0.5776|||37.7107|40|0.18||26.691|24.191|5.953|6.931|6.931||35.97|35.97|1182.9307|173269.6667|260.4208|34.66|34.66
russ2000_2_0209|EIDX|201912|195.92|191.157||5.269||32.393|10.43|21.963||171.427|-103.105||||-62.9996|11.2251|||12.7352|||0||6.4505|0.085|3.467|0.038|||10|-1.8102|||37.4287|45|-0.51|||0|5.466|-18.98|-18.98||57.39|57.39|2008.1108|209826.6|317.0785|57.62|57.62
russ2000_2_0209|EIDX|202003|200.592|196.515||5.18||33.745|11.82|21.925||174.852|-125.929||||-41.9542|9.5438|||10.795|||0||5.0411|0.125|4.295|0.039|||10|0.3304|||38.0096|47|-0.6||||5.311|-22.824|-22.824|-0.518|48.99|48.99|1707.3269|148254.1333|108.9126|45.23|45.23
russ2000_2_0209|EIDX|202006|178.793|174.821||5.098||37.359|15.389|21.97||149.311|-154.778||||-35.8311|9.3905|||12.3112|||0||5.083|0.154|2.599|0.039|||9|0.153|||38.2914|64|-0.75||||10.317|-28.849|-28.849|-0.604|47.67|47.67|1679.9039|106366.3333|53.3784|48.04|48.04
russ2000_2_0209|EIDX|202009|||||||||||||||-38.1941||||13.0532|||0||5.0532||||||6|0.0323|||||||||||||50.53|50.53|1790.6936|73879.2333|40.4782|52.08|52.08